Schwartz’s primary research areas include early diagnosis and treatment of diseases such as macular degeneration, retinopathy of prematurity (ROP), and diabetic eye disease. Schwartz raises the bar as a physician, educator, and, of course, innovator.

Patients often experience a very profound sense of depression. This week we shift gears back to R for the OIS Retina Podcast with Firas Rahhal, MD, and his esteemed guest Steven Schwartz, MD, chief of the retina division at the Jules Stein Eye Institute, UCLA. Steven D Schwartz, MD Chief, Retina Division Jules Stein Eye Institute, UCLA. He received his medical degree from the USC School of Medicine, completed an Internship at the USC Hospital in Medicine, Surgery, and Anesthesia, a Residency in Ophthalmology at UCLA School of Medicine, Jules Stein Eye Institute, and a Fellowship in Retina/Uveitis at the UCL Institute of Ophthalmology, Moorfields Eye Hospital.ĭr. The UCLA Stein Eye Institute was established in 1966 by Jules Stein, MD, and Bradley Straatsma, MD, JD, founding chairman of. Click here to watch the video version of this podcast. Schwartz is currently serving as Ahmanson Professor of Ophthalmology, Professor-in-Residence of Ophthalmology, Chief of Retina Division, Director for Diabetic Eye Disease and Retinal Vascular Center, and Director of the Ophthalmic Photography Clinical Laboratory for Jules Stein Eye Institute of UCLA. The American Macular Degeneration Foundation has more on macular degeneration and Stargardt disease.Dr. Internship: 1996 - 1997 Brackenridge Hospital. Fellowship: 2000 - 2002 UC San Francisco School of Medicine. Education: Degrees: M.D., University of Texas Medical Branch at Galveston, 1996. Schwartz told the New York Times that the findings are 'a big step forward for regenerative medicine.' UCLA Chief, Cornea and Uveitis Professor, Ophthalmology Member, Laser Refractive Center Member, Stein Eye Institute. (310) 206-7474 View Locations Overview Awards & Credentials Insurance Hospital About Dr. This study was only one of two human embryonic stem cells currently approved by the FDA, but the other study on treating spinal cord injury discontinued, according to the New York Times.Ī third stem cell surgery was performed on a British patient at Moorfields Eye Hospital in London, according to the written statement, and had no complications. But cells come from the destruction of human embryos, which raises ethical red flags for many. Shlomit Schaal, MD, PhD, MHCM will become the new president and CEO of the Houston Methodist Physician. Schwartz is affiliated with Ronald Reagan UCLA Medical Center. In these cases, the cells were used to create retinal pigment epithelial cells that protect and provide nutrition for cells that sense light. He works in Los Angeles, CA and 1 other location and specializes in Ophthalmology.

Unsubscribe from all UCLA Health email newsletters. Email updates with news and time sensitive content. You can also find other Doctors on MapQuest. Bi-weekly email covering vital health news, tips and information. Get directions, reviews and information for Steven D Schwartz MD - UCLA Stein Eye Institute in Los Angeles, CA. Jules Stein Eye Institute 100 Stein Plaza, UCLA Box 957000 Los Angeles, CA 900957000 (310) 206-6035 The Foundation Fighting Blindness continued. The cells can morph into other types of cells, fueling scientists' hopes that they can be used to treat diseases. Please select the email (s) you wish to receive: Healthy Living Newsletter. Jules Stein Eye Institute T oday, scientific progress is moving with unprecedented speed. Using human embryonic stem cells for research has been a controversial issue since the cells' discovery in 1998, according to the study authors.

Dr steven schwartz ucla jules stein